An Phat Bioplastics JSC Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

22,24,065.40

21,92,291.13

23,69,473.91

23,09,974.27

38,56,408.10

38,42,644.52

31,93,399.54

Other Operating Income

0.00

Total Operating income

22,24,065.40

21,92,291.13

23,69,473.91

23,09,974.27

38,56,408.10

38,42,644.52

31,93,399.54

Raw Material Cost

18,64,254.85

18,64,920.07

20,21,865.54

19,55,834.76

33,92,693.59

33,89,271.00

28,48,063.51

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

30,230.43

35,103.76

25,986.17

46,436.43

1,59,809.74

61,116.23

36,988.66

Selling and Distribution Expenses

1,92,065.35

2,28,388.21

2,08,287.91

2,27,578.28

2,79,771.75

3,75,625.68

3,74,787.15

Other Expenses

-3,023.04

-3,510.38

-2,598.62

-4,643.64

-15,980.97

-6,111.62

-3,698.87

Total Expenditure (Excl Depreciation)

20,56,320.20

20,93,308.28

22,30,153.45

21,83,413.04

36,72,465.34

37,64,896.68

32,22,850.65

Operating Profit (PBDIT) excl Other Income

167745.2

98982.8

139320.5

126561.20000000001

183942.8

77747.8

-29451.100000000002

Other Income

59,634.39

37,673.53

42,843.26

1,21,681.24

44,357.22

74,047.42

38,524.54

Operating Profit (PBDIT)

3,47,615.92

2,61,983.55

3,05,643.29

3,72,440.63

3,59,983.84

2,92,633.87

90,879.57

Interest

30,230.43

35,103.76

25,986.17

46,436.43

1,59,809.74

61,116.23

36,988.66

Exceptional Items

0.00

Gross Profit (PBDT)

3,59,810.54

3,27,371.05

3,47,608.36

3,54,139.51

4,63,714.51

4,53,373.51

3,45,336.03

Depreciation

1,20,236.33

1,25,327.17

1,23,479.57

1,24,198.17

1,31,683.85

1,40,838.61

81,806.15

Profit Before Tax

1,97,149.16

1,01,552.62

1,56,177.54

2,01,806.03

68,490.24

90,679.03

-27,915.23

Tax

34,550.45

39,530.77

30,750.70

30,040.03

12,977.82

36,658.51

-2,213.33

Provisions and contingencies

0.00

Profit After Tax

1,53,668.06

78,429.32

1,17,554.44

1,21,348.93

45,239.81

69,439.64

21,799.60

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,53,668.06

78,429.32

1,17,554.44

1,21,348.93

45,239.81

69,439.64

21,799.60

Share in Profit of Associates

0.00

Minority Interest

8,930.65

-16,407.47

7,872.40

50,417.07

10,272.61

-15,419.12

-47,501.50

Other related items

0.00

Consolidated Net Profit

1,62,598.71

62,021.85

1,25,426.84

1,71,766.01

55,512.42

54,020.52

-25,701.90

Equity Capital

0.00

Face Value

10000.0

Reserves

56,14,189.30

54,68,424.84

53,87,931.48

52,49,369.54

53,87,890.21

53,33,818.64

50,54,126.54

Earnings per share (EPS)

390.28

199.19

298.56

317.44

118.34

181.65

57.03

Diluted Earnings per share

390.28

199.19

298.56

317.44

118.34

181.65

57.03

Operating Profit Margin (Excl OI)

7.54%

4.52%

5.88%

5.48%

4.77%

2.02%

-0.92%

Gross Profit Margin

14.27%

10.35%

11.8%

14.11%

5.19%

6.02%

1.69%

PAT Margin

6.91%

3.58%

4.96%

5.25%

1.17%

1.81%

0.68%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is 1.45% vs -7.48% in Dec 2025

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 162.16% vs -50.55% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 28.39% vs -14.65% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is -13.88% vs 35.09% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of An Phat Bioplastics JSC With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(VND)

Change(%)

Net Sales

22,24,065.40

14,48,211.73

7,75,853.67

53.57%

Other Operating Income

0.00

Total Operating income

22,24,065.40

14,48,211.73

7,75,853.67

53.57%

Raw Material Cost

18,64,254.85

13,48,088.05

5,16,166.80

38.29%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

88,714.26

-88,714.26

-100.00%

Power Cost

0.00

Manufacturing Expenses

30,230.43

52,760.28

-22,529.85

-42.70%

Selling and Distribution Expenses

1,92,065.35

28,087.69

1,63,977.66

583.81%

Other Expenses

-3,023.04

-14,147.45

11,124.41

78.63%

Total Expenditure (Excl Depreciation)

20,56,320.20

13,76,175.74

6,80,144.46

49.42%

Operating Profit (PBDIT) excl Other Income

1,67,745.20

72,035.99

95,709.21

132.86%

Other Income

59,634.39

23,784.79

35,849.60

150.72%

Operating Profit (PBDIT)

3,47,615.92

1,33,922.51

2,13,693.41

159.56%

Interest

30,230.43

52,760.28

-22,529.85

-42.70%

Exceptional Items

0.00

Gross Profit (PBDT)

3,59,810.54

1,00,123.68

2,59,686.86

259.37%

Depreciation

1,20,236.33

38,511.28

81,725.05

212.21%

Profit Before Tax

1,97,149.16

42,650.95

1,54,498.21

362.24%

Tax

34,550.45

10,255.86

24,294.59

236.88%

Provisions and contingencies

0.00

Profit After Tax

1,53,668.06

32,395.09

1,21,272.97

374.36%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,53,668.06

32,395.09

1,21,272.97

374.36%

Share in Profit of Associates

0.00

Minority Interest

8,930.65

0.00

8,930.65

Other related items

0.00

Consolidated Net Profit

1,62,598.71

32,395.09

1,30,203.62

401.92%

Equity Capital

0.00

Face Value

10,000.00

0.00

Reserves

56,14,189.30

12,30,826.32

43,83,362.98

356.13%

Earnings per share (EPS)

390.28

356.14

34.14

9.59%

Diluted Earnings per share

390.28

356.14

34.14

9.59%

Operating Profit Margin (Excl OI)

7.54%

4.95%

0.00

2.59%

Gross Profit Margin

14.27%

5.60%

0.00

8.67%

PAT Margin

6.91%

2.24%

0.00

4.67%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 2,22,406.54 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 1.45% vs -7.48% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -42.33% vs 30.12% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 16,259.87 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 162.16% vs -50.55% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 192.91% vs -61.42% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 28,798.15 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 28.39% vs -14.65% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -8.76% vs 39.30% in Mar 2025

Quarterly - Interest

Interest 3,023.04 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -13.88% vs 35.09% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -81.08% vs 301.52% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 7.54%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025